Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
23.01.23 | Ultimovacs - Phase II milestone as licensing potential nears | 469 | Edison Investment Research | Ultimovacs has announced that patient enrolment has been completed (n=118) for the ongoing Phase II NIPU study investigating the company's lead cancer vaccine candidate, UV1, in combination with immune... ► Artikel lesen | |
23.01.23 | Medlab Clinical - NanaBis development centre stage in 2023 | 270 | Edison Investment Research | As Medlab Clinical moves into 2023, the expected commencement of a Phase III trial for NanaBis (the company's cannabinoid based analgesic therapy) in cancer-induced bone pain will be the focus for investors.... ► Artikel lesen | |
23.01.23 | Round Hill Music Royalty Fund - Strong royalty performance | 410 | Edison Investment Research | A healthy music-streaming market coupled with Round Hill Music Royalty Fund's (RHMRF's) attractive portfolio resulted in a strong net publisher's share (NPS) performance in 9M22, up 36.1% y-o-y to $21.8m.... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 329 |
EVOTEC | 292 |
TUI | 209 |
NVIDIA | 179 |
DEUTSCHE BANK | 171 |
BAYER | 157 |
PLUG POWER | 144 |
NEL | 135 |
RHEINMETALL | 133 |
BARRICK GOLD | 111 |
SIEMENS ENERGY | 110 |
COMMERZBANK | 107 |
TESLA | 103 |
BASF | 102 |
VOLKSWAGEN | 93 |
RWE | 90 |
BYD | 87 |
DEUTSCHE LUFTHANSA | 85 |
ALLIANZ | 83 |
MERCEDES-BENZ | 79 |
RENK GROUP | 79 |
HEIDELBERGER DRUCK | 76 |
DEUTSCHE TELEKOM | 75 |
ALIBABA | 72 |
E.ON | 69 |